Body Fat Distribution and Your Genetics

Body fat distribution refers to where the body stores fat—whether proportionally in subcutaneous depots beneath the skin or preferentially in visceral locations around the abdominal organs. Genome-wide association studies (GWAS) of fat distribution traits reveal genetic variants that influence this patterning, operating through pathways that include the cellular signaling networks controlling how fat cells respond to hormonal cues and the developmental biology governing how progenitor cells decide whether to become fat cells at all. Two recurring themes in recent GWAS of fat distribution are cyclic AMP (cAMP) signaling through adenylyl cyclase enzymes and the Wnt/β-catenin developmental pathway that regulates adipocyte differentiation.

What is body fat distribution?

Body fat distribution describes the anatomical location of adipose tissue accumulation and the proportional balance between different fat compartments. This distinction matters metabolically: visceral fat, which accumulates intra-abdominally around organs such as the liver, pancreas, and gut, is metabolically more active than subcutaneous fat and releases a different profile of fatty acids and inflammatory signals into the portal circulation. Visceral adiposity is more closely associated with insulin resistance, dyslipidemia, elevated triglycerides, and cardiovascular risk than total fat mass measured by BMI alone.

The measures used in GWAS of fat distribution include waist circumference, hip circumference, waist-to-hip ratio (WHR), and imaging-derived estimates of visceral versus subcutaneous fat volume from MRI or DXA scans. Studies using WHR adjusted for BMI (WHRadjBMI) isolate the distributional component of fat patterning from total adiposity, allowing genetic factors that specifically influence where fat is stored—rather than how much total fat is present—to be identified.

At the cellular level, body fat distribution is shaped by two related but distinct processes: the capacity of adipose tissue progenitors in different depots to generate new fat cells (adipogenesis), and the responsiveness of mature adipocytes in each depot to hormonal signals governing fat storage and mobilization. Genetic variation in genes controlling either process can produce characteristic fat distribution patterns that persist across a range of body weights.

The genetics behind body fat distribution

Fat distribution is a moderately heritable polygenic trait. Population and twin studies estimate that genetics accounts for 30 to 50 percent of variation in waist-to-hip ratio and related fat distribution measures, with many contributing loci each explaining a small fraction of the total variance.

Among the genes at GWAS loci for body fat distribution, ADCY3 encodes adenylyl cyclase 3, a membrane-spanning enzyme that synthesizes cyclic AMP (cAMP) from ATP in response to G protein-coupled receptor activation. cAMP is the canonical second messenger through which catecholamines—epinephrine and norepinephrine released during physical or metabolic stress—stimulate lipolysis in adipose tissue. When beta-adrenergic receptors on fat cells are activated, adenylyl cyclase generates cAMP, which activates protein kinase A (PKA), which in turn phosphorylates hormone-sensitive lipase and perilipin to initiate fat breakdown and fatty acid release. ADCY3 variants that alter adenylyl cyclase activity or expression in adipose tissue can therefore influence how efficiently fat cells respond to lipolytic signals, potentially affecting where fat accumulates over time relative to how readily it is mobilized from each depot.

ADCY9 encodes a related adenylyl cyclase isoform expressed in metabolically relevant tissues. Like ADCY3, ADCY9 generates cAMP in response to receptor signaling, but its expression pattern and regulatory relationships differ from those of ADCY3. The presence of multiple adenylyl cyclase family members among GWAS loci for fat distribution phenotypes suggests that cAMP-mediated adrenergic signaling in adipose tissue is a recurring mechanism through which genetic variation shapes fat patterning—not through a single gene, but through multiple nodes in the same signaling pathway.

APC encodes adenomatous polyposis coli, a scaffolding protein with a central role in the Wnt/β-catenin signaling pathway. APC is a component of the β-catenin destruction complex—a molecular assembly that, in the absence of Wnt ligand signaling, continuously marks β-catenin for proteasomal degradation. When Wnt pathway ligands engage Frizzled receptors and LRP co-receptors, APC-mediated destruction is suppressed, β-catenin accumulates in the cytoplasm and nucleus, and β-catenin-dependent transcriptional programs are activated. This pathway is a central regulator of mesenchymal progenitor cell fate: active Wnt/β-catenin signaling promotes osteoblast differentiation while suppressing adipogenesis, and attenuated Wnt signaling shifts the balance in the opposite direction. Variants at the APC locus that alter the set-point of the β-catenin destruction complex in adipose tissue progenitors can therefore influence how readily those progenitors commit to fat cell identity, affecting depot-level adipogenesis and fat distribution patterns.

What the research says

Research base: Moderate

Large-scale GWAS of body fat distribution have substantially expanded the biological pathways implicated in fat patterning beyond simple energy balance.

A large-scale genome-wide association study of body fat distribution identified loci distributed across multiple biological pathways including cAMP-mediated signaling through adenylyl cyclase enzymes and developmental pathway regulators involved in adipocyte fate determination. The study extended the catalog of fat distribution loci into cellular signaling and gene regulatory domains beyond the established metabolic and hormonal pathways (Author et al., 2024, PMID: 38965376).

The genetics of fat distribution is distinct from the genetics of total body weight or BMI. Different sets of genetic variants influence how much total fat is present versus where it is distributed—a dissociation that reflects the distinct biological processes at work. Genes affecting overall energy homeostasis and appetite regulation contribute mainly to total adiposity, while genes affecting adipocyte differentiation capacity in specific depots or the lipolytic responsiveness of different fat compartments contribute specifically to fat distribution.

Genome-wide association studies using WHR adjusted for BMI (WHRadjBMI) consistently identify loci in developmental regulatory and cellular signaling pathways, suggesting that fat patterning is driven in part by adipose tissue progenitor biology and depot-specific responsiveness to lipolytic signals, rather than energy intake and expenditure alone. The recurring enrichment of adrenergic signaling and Wnt pathway genes in these results implicates two distinct cellular mechanisms in determining where fat is stored.

Polygenic scores for fat distribution traits constructed from GWAS findings predict cardiometabolic risk markers including waist circumference, fasting insulin, triglycerides, and visceral fat area in independent populations, consistent with the metabolic consequences of central adiposity that are distinct from those of total body weight.

How body fat distribution affects you

Genetic tendencies toward particular fat distribution patterns represent probabilistic population-level associations, not individual predictions. Many individuals with high polygenic scores for central fat distribution maintain favorable body composition through lifestyle choices, and many with lower genetic scores develop central adiposity through environmental and behavioral factors.

The pathways highlighted by GWAS—adenylyl cyclase-mediated cAMP signaling and Wnt-regulated adipocyte differentiation—suggest that fat distribution is shaped partly by how responsive different adipose depots are to hormonal mobilization signals and partly by the fundamental capacity of progenitor cells in those depots to generate new fat cells. These mechanisms operate substantially independently of total caloric intake, which is one reason fat distribution patterns can be quite consistent within individuals across a range of weights.

Working with your body fat distribution profile

The ExomeDNA body fat distribution result reflects genetic associations from population-scale GWAS and should be interpreted as a probabilistic tendency. The following lifestyle factors have the most consistent research evidence for influencing fat distribution:

• Aerobic exercise: Regular cardiovascular exercise preferentially reduces visceral fat relative to subcutaneous fat, independently of total weight change. Effects on visceral adiposity are detectable within weeks of starting an exercise program across diverse genetic backgrounds.
• Dietary quality: Diets lower in refined carbohydrates and added sugars are associated with favorable shifts in fat distribution in clinical trials, independently of caloric restriction, possibly through effects on insulin and cAMP signaling in adipose tissue.
• Sleep quality and duration: Short sleep duration and poor sleep quality are associated with greater visceral fat accumulation through effects on cortisol and insulin signaling.
• Stress management: Chronic stress elevates cortisol, which selectively promotes visceral over subcutaneous fat deposition. Reducing chronic stress exposure may have disproportionate effects on central fat distribution relative to total body weight.

For personalized guidance about body fat distribution and metabolic health, a healthcare professional, registered dietitian, or endocrinologist can provide individualized support.

Research base: Moderate. This genetic association is supported by large-scale population GWAS evidence. Association does not imply causation, and individual outcomes depend on many genetic and non-genetic factors. See our methodology page for how ExomeDNA evaluates evidence quality.

Related traits and genes

Body fat distribution shares genetic architecture with BMI, waist-to-hip ratio, visceral adiposity, and downstream cardiometabolic traits. The cAMP signaling genes implicated at GWAS loci—ADCY3 and ADCY9—connect fat distribution genetics to adrenergic signaling biology that also shapes cardiovascular traits and metabolic rate. APC links fat distribution to Wnt/β-catenin developmental pathway regulation of adipocyte differentiation, a pathway with roles across multiple metabolic tissue types.

Related traits: BMI Genetics | Waist-to-Hip Ratio | Body Weight Genetics | Visceral Adiposity | Triglyceride Levels

Frequently asked questions

Is body fat distribution genetic? Yes. Twin and family studies estimate that 30 to 50 percent of variation in fat distribution measures such as waist-to-hip ratio is attributable to genetic factors. GWAS have identified hundreds of loci distributed across signaling and developmental pathways, including cAMP-generating adenylyl cyclases and the Wnt/β-catenin pathway regulator APC.

What is ADCY3 and how does it relate to fat distribution? ADCY3 encodes adenylyl cyclase 3, the enzyme that synthesizes cAMP in adipose tissue in response to catecholamine signaling through beta-adrenergic receptors. cAMP drives lipolysis through a cascade involving protein kinase A and hormone-sensitive lipase. Variants at the ADCY3 locus can alter how readily fat cells respond to adrenergic mobilization signals, potentially affecting how fat accumulates and is released across different body depots over time.

What is APC and how does the Wnt pathway affect fat distribution? APC encodes a component of the β-catenin destruction complex in the Wnt signaling pathway. When Wnt signaling is active, APC-mediated β-catenin destruction is suppressed, and transcriptional programs promoting osteoblast differentiation and inhibiting adipogenesis are activated. Variants at the APC locus can shift the threshold of this pathway in adipose tissue progenitors, influencing how readily progenitor cells commit to adipocyte identity in different fat depots.

Can lifestyle changes affect fat distribution regardless of genetics? Yes. Aerobic exercise consistently reduces visceral fat across a range of genetic backgrounds. Dietary quality, sleep, and stress management also influence central fat distribution through hormonal and metabolic mechanisms that operate independently of genetic tendency.

Why does fat distribution matter beyond total body weight? Visceral fat is metabolically distinct from subcutaneous fat: it releases a different profile of fatty acids and inflammatory signals into the portal circulation and is more closely associated with insulin resistance, dyslipidemia, and cardiovascular risk than total fat mass alone. This is why body composition and fat distribution are increasingly used to assess metabolic health in addition to BMI.

Written by Scott Peeples, BS Biomedical Sciences | ExomeDNA Founder Reviewed by ExomeDNA Editorial Process

Results are not a clinical test, not a treatment recommendation, and not a substitute for professional healthcare. This page provides wellness education and is not a substitute for clinical care.

References

1. Author et al. (2024). Genome-wide association study of body fat distribution. PMID: 38965376.

Data sources: GWAS Catalog | Open Targets | ClinVar | ClinGen

Additional research: body fat distribution (waist circumference adjusted for BMI)

The genetics behind body fat distribution

Research base: Moderate.

The genetic basis of body fat distribution operates substantially through extracellular matrix (ECM) remodeling in adipose tissue. Adipose tissue has an elaborate scaffold of collagen, proteoglycans, and glycoproteins determining how each fat depot expands, stiffens, and responds to metabolic signals.

ADAMTS3 encodes a metalloproteinase that processes procollagen type II, required for fibrillar collagen assembly. In adipose tissue, ECM composition and stiffness differ significantly between visceral and subcutaneous depots. ADAMTS3 remodels the collagen-proteoglycan matrix of these depots, influencing whether fat preferentially accumulates centrally or peripherally. Visceral adipose tissue typically has a stiffer, less expansible ECM architecture than subcutaneous adipose; ADAMTS3 variants that alter collagen processing may shift this balance.

ADAMTS9 is a closely related metalloprotease that cleaves versican and aggrecan — two major proteoglycans in the adipose ECM. Versican and aggrecan regulate ECM stiffness and the mechanical properties of fat depots. ADAMTS9 variants alter ECM dynamics in a depot-specific way: differences in versican turnover between visceral and subcutaneous adipose affect adipocyte differentiation and expansion capacity. Research suggests that ECM stiffness influences whether preadipocytes preferentially differentiate in central versus peripheral depots (Graff et al. 2017).

ADAMTSL3 encodes an ADAMTS-like protein that modulates the activity of ADAMTS metalloproteases and regulates fibrillin microfibril assembly. Fibrillin microfibrils form the scaffolding networks that surround adipocytes and shape depot architecture. Variants in ADAMTSL3 that alter microfibril networks could influence the structural environment of visceral versus subcutaneous fat compartments.

ACAN encodes aggrecan, the major large proteoglycan of ECM tissues. Aggrecan forms enormous aggregates with hyaluronan, creating the gel-like ECM infrastructure that determines tissue mechanical properties. Visceral adipose tissue has higher ECM rigidity in part because of its aggrecan content and organization. ACAN variants that alter aggrecan production or structure may affect the mechanical expandability of fat depots in different body compartments, shaping which depot fills first as fat mass increases.

BCKDHB introduces a distinct metabolic mechanism. It encodes the E1-beta subunit of the branched-chain keto acid dehydrogenase complex, the rate-limiting enzyme in BCAA (leucine, isoleucine, valine) catabolism. When BCKDHB activity is reduced, BCAAs accumulate in plasma. Elevated BCAAs are a robust biomarker of insulin resistance. Visceral adipose tissue has lower BCAA-catabolizing activity than subcutaneous fat, creating a self-reinforcing cycle between central adiposity and impaired BCAA metabolism.

Together, these five genes sketch a picture of body fat distribution driven by ECM scaffold architecture (ADAMTS3, ADAMTS9, ADAMTSL3, ACAN) and metabolic signaling through BCAA pathways (BCKDHB) — two largely independent biological axes converging on the same phenotype.

What the research says

The WHRadjBMI measure is analytically designed to isolate fat distribution from total fat mass. By adjusting waist circumference for BMI before running association analyses, the GWAS specifically targets genetic variants that shape WHERE fat is stored rather than confounding distribution genetics with total obesity genetics. This methodological choice is scientifically meaningful: it identified a distinct set of loci from BMI GWAS hits, confirming that distribution and quantity are genetically separable phenotypes.

Evidence in non-European ancestries is less complete. The largest WHRadjBMI meta-analyses have been conducted primarily in European-ancestry cohorts, with some multi-ancestry replication. Effect sizes and locus-specific signals may differ across ancestral backgrounds. ExomeDNA scores are calibrated using ancestry-aware percentile normalization — see our methodology for the full statistical approach.

References (body fat distribution (waist circumference adjusted for BMI))

1. Graff M, Scott RA, Justice AE, et al. (2017). Genome-wide physical activity interactions in adiposity — A meta-analysis of 200,452 adults. PLOS Genetics. PMID: 28448500.

Additional research: body fat distribution (additional study)

The genetics behind body fat distribution

Fat distribution is a polygenic trait, meaning hundreds to thousands of common genetic variants each contribute a small amount to the overall pattern. Large-scale genome-wide association studies (GWAS) have identified dozens of loci reaching statistical significance, with additional signals likely to emerge as sample sizes grow.

Among the genes at associated loci in the research literature, several fall within a biologically coherent framework involving extracellular matrix (ECM) regulation and adipose tissue architecture. The ECM provides the structural scaffolding within which adipocytes reside, and its composition and remodeling capacity influence how and where fat is stored. ADAMTS9 encodes a secreted metalloproteinase in the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family—enzymes with established roles in ECM remodeling, proteoglycan cleavage, and tissue architecture maintenance. Research has associated variants in genomic regions near ADAMTS9 with measures of body fat distribution in large GWAS.

ACAN encodes aggrecan, the most abundant proteoglycan in the extracellular matrix of cartilaginous tissues, where it interacts with hyaluronan to form large aggregates that withstand compression. Aggrecan and related proteoglycans are structural components of the ECM in multiple tissue types, and their function intersects with adipose tissue organization. Similarly, ADAMTS10, another member of the ADAMTS family, participates in ECM proteoglycan processing and has been implicated in body composition phenotypes in genetic research.

The genetic architecture of fat distribution shows considerable complexity. Individual variants typically explain a fraction of a percentage point of variance, but in aggregate, common variants explain a modest but detectable proportion of population variation in fat distribution patterns.

What the research says

Research base: Moderate

The study of fat distribution genetics has benefited from large consortium GWAS, enabling detection of loci that would be invisible in smaller samples.

A large genome-wide association analysis spanning hundreds of thousands of adults across European and other ancestries identified dozens of loci significantly associated with measures of body fat distribution, including waist-to-hip ratio adjusted for BMI (WHRadjBMI). Several loci showed markedly stronger effects in females than in males, highlighting the sex-specific genetic architecture of fat patterning (2017, PMID: 28443625).

Fat distribution heritability estimates from twin and family studies typically range from 30 to 55 percent, suggesting that a substantial portion of population variance in fat patterning is attributable to genetic differences, with the remainder driven by environmental, behavioral, and developmental factors.

Twin studies examining WHRadjBMI and other fat distribution indices report heritability estimates in the range of 30–55%, indicating that genetic factors contribute meaningfully to where individuals store fat, even after adjusting for total body mass.

These aggregate effects are captured in polygenic scores—summaries of many variants that together explain more variance than any single locus. At the population level, polygenic scores for fat distribution show modest but statistically robust correlations with measured fat patterning indices such as WHRadjBMI and waist circumference.